Home - Clinical Trials Arena
WEBAt the Clinical Trial Supply West Coast 2024 conference, serial biotech entrepreneur Umar Hayat said science should be allowed to advance without political interference. Catherine Longworth. Analyst Comment.
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 · According to a report by GlobalData, the market for obesity drugs is predicted to be worth $37.1bn in 2031. GlobalData is a parent company of the Clinical Trials Arena. As more trials take place globally, not only will this help to provide a wider range of treatments for patients but will also assist the unmet need of lack of supply.
About Us Online - Clinical Trials Arena
WEBAbout Us. Clinicaltrialsarena.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone – from senior management through to research and QA ...
News - Clinical Trials Arena
WEBIpsen shelves Cabometyx combo in prostate cancer after Phase III miss. One of Ipsen’s flagship oncology assets Cabometyx (cabozantinib) will not be gaining an indication in prostate cancer outside the US…. Robert Barrie. News.
CRO consolidation: is the clinical trials industry reaching a tipping ...
WEBNov 2, 2022 · Labcorp announced the spinoff of its drug development and clinical trials arm in August 2022, called Clinical Development Business, which will now operate as a CRO offering Phase I–IV clinical trial management and technology to the biopharma industry. Labcorp will retain the laboratory business that is related to routine and esoteric labs, central labs, and early development research labs.
Outsourcing trends in clinical trials: How one company is …
WEBSep 18, 2023 · George Sawicki (GS): There is certainly a gravitational pull to the FSP model. Many larger FSP players have now been acquired by CROs, which has made them even bigger. We’ve noticed a lot more traction for a company that’s our size; companies that use more of a boutique shop while always ensuring the number one priority is quality.
Clinical trials in China - is it worth climbing the great wall?
WEBMay 13, 2022 · The great wall: why overseas sponsors are yet to fully tap into China’s clinical trial resources. China is an attractive study destination, yet our data-driven analysis shows the country’s clinical trial industry is still insular. Clinical Trials Arena maps the barricades. Reynald Castañeda and Andrew Hillman May 13, 2022. Need to know ...
Trial termination analysis unveils a silver lining for patient ...
WEBOct 23, 2022 · The proportion of trials ending prematurely has been decreasing steadily over the past decade. Our exclusive analysis shows that the clinical trial termination rate has fallen from 10.6% in 2010 to 4.7% in 2021. Such a trend can partly be the result of technology applications, digitisation, and changes in the trial space as decentralised ...
Pharma Technology Focus Magazine - Clinical Trials Arena
WEBIn this issue: UK’s new the UK's Netflix-style funding model for antibiotics, the Swiss biotech ecosystem’s recuperates from financial instability of 2023, how patient advocacy can lead to more successful clinical trials, and more. Whether you want to increase brand awareness, deliver a complex message or launch a new product, our online ...
Five AI-enhanced clinical trial start-ups to watch in 2021
WEBJul 29, 2021 · Unlearn.AI is a San Francisco startup founded in 2017 by former Pfizer principal scientist Charles Fisher. The firm claims to be the first to create ‘digital twins’ to populate intelligent control arms in clinical studies. In the context of clinical research, Unlearn explains, a digital twin is a “longitudinal, computationally generated ...
Skip to content